Could a Four-Times-a-Year shot replace daily pills for breast cancer?
NCT ID NCT07401381
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This study tests whether a new quarterly injection of letrozole delivers the same amount of medicine into the body as the standard daily pill. It involves 120 postmenopausal women who have already completed at least 4-5 years of hormone therapy for early breast cancer. The goal is to see if the injection can offer a more convenient dosing option while maintaining similar drug levels and safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clínico Universitario Virgen de la Arrixaca (Investigational Site number ESP-009)
RECRUITINGMurcia, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.